WORKIVA INC

Departure of Chief Financial Officer

As previously disclosed in its quarterly report on Form 10-Q for the period ended June 30, 2025, the Company announced that Jill E. Klindt, Executive Vice President, Chief Financial Officer ("CFO") and Treasurer of the Company will be stepping down in 2025 following a transition period.

In connection with her departure and in order to facilitate an orderly transition, the Company and Ms. Klindt entered into a Severance and Transition Services Agreement (the "Agreement") on October 30, 2025. The Agreement will be effective as of November 7, 2025 (the "Effective Date"), following the end of a seven-day revocation period. The Agreement provides that Ms. Klindt's employment will end on December 26, 2025, unless terminated earlier by either party (the "Termination Date"). Ms. Klindt will remain as CFO until the earlier of the Termination Date or the date on which a new CFO is hired.

The Agreement further provides that the Company will pay Ms. Klindt a lump-sum cash severance payment of $1,928,321.53 within 10 business days after the Termination Date, in accordance with the amount payable in connection with a termination without cause under Ms. Klindt's employment agreement. Additionally, Ms. Klindt's outstanding stock or equity-based compensation awards that have not yet vested as of the Termination Date will vest as of the Termination Date, with performance-based awards vesting at target performance. If Ms. Klindt elects continuation coverage under COBRA, the Company will continue to make payments for her health insurance coverage for 18 months or until Ms. Klindt becomes eligible to receive coverage from another employer, whichever occurs first. Additionally, if a change in control (as such term is defined in Ms. Klindt’s employment agreement) of the Company occurs within three months following the Termination Date, Ms. Klindt will be entitled to receive an additional lump-sum cash payment of $1,075,000, in accordance with Ms. Klindt’s employment agreement. Finally, the Agreement includes other standard provisions contained in agreements of this nature, including non-disparagement, confidentiality, and a general release of any and all claims against the Company. The foregoing summary of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, which is filed herewith as Exhibit 10.1.

The Company appreciates Ms. Klindt's service and commitment and wishes her well.

Departure of Chief Sales Officer

On November 5, 2025 the Company announced that Michael Hawkins, Executive Vice President, Chief Sales Officer ("CSO") of the Company, will be stepping down, effective November 5, 2025.

In connection with his departure, the Company has entered into a Severance Agreement and General Release on October 30, 2025 (the “Severance and Release Agreement”), which will be effective following the end of a seven-day revocation period. The Severance and Release Agreement includes a consulting arrangement between the Company and Mr. Hawkins, effective from November 7, 2025 until December 31, 2025, which provides for payment of $10,000 per month to Mr. Hawkins to consult on a periodic basis with the CEO concerning the Company’s sales function and to ensure a smooth transition. This agreement includes standard provisions contained in agreements of this nature, including non-disparagement, confidentiality, and a general release of any and all claims against the Company.

Further, pursuant to the terms of Mr. Hawkins’s Employment Agreement dated August 12, 2021, Mr. Hawkins’s departure will be deemed a termination without cause (as such term is defined in his employment agreement). Accordingly, the Company will pay Mr. Hawkins a lump-sum cash severance payment of $2,124,087.61 within 10 business days after the Termination Date (as such term is defined in his employment agreement), in accordance with the amount payable in connection with a termination without cause under his employment agreement. Additionally, Mr. Hawkins's outstanding stock or equity-based compensation awards that have not yet vested as of the Termination Date will vest as of the Termination Date, with performance-based awards vesting at target performance. If Mr. Hawkins elects continuation coverage under COBRA, the Company will continue to make payments for his health insurance coverage for 18 months or until Mr. Hawkins becomes eligible to receive coverage from another employer, whichever occurs first. Additionally, if a change in control of the Company occurs within three months following the Termination Date, Mr. Hawkins will be entitled to receive an additional lump-sum cash payment of $1,237,600, in accordance with his employment agreement. The foregoing summary of the Severance and Release Agreement does not purport to be complete and is qualified in its entirety by reference to the Severance and Release Agreement, which is filed herewith as Exhibit 10.2.

Mr. Hawkins departure was not the result of any disagreement with the Company or its management on any matter relating to the Company’s operations, policies or practices.

The Company appreciates Mr. Hawkins service and commitment and wishes him well.

Director and Officer Trading Arrangements

During the three months ended September 30, 2025, no director or officer of the Company adopted, modified orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.